DDX3X and Ewing sarcoma: DDX3 exerts oncogenic roles in glioblastoma (160, 161), meningioma (162), Ewing sarcoma (68), prostate cancer (134), chronic lymphocytic leukemia (163, 164), pancreatic ductal adenocarcinoma (165), and gallbladder cancer (126).